Genome-wide association study of skin complex diseases

Journal of Dermatological Science

Volumn 66, Issue 2, 2012, Pages 89-97

  Zhang, Xuejun ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Genetic; Genome wide association study; Skin complex diseases

Indexed keywords

ANTIGEN EXPRESSION; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; CARCINOGENESIS; COPY NUMBER VARIATION; CUTANEOUS MELANOMA; EPIGENETICS; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; KELOID; LEPROSY; MALE TYPE ALOPECIA; MELANOMA; MOLECULAR PATHOLOGY; NEVUS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SARCOIDOSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

ALOPECIA; CARCINOMA, BASAL CELL; DERMATITIS, ATOPIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KELOID; LEPROSY, LEPROMATOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MELANOMA; NEVUS; PSORIASIS; SARCOIDOSIS; SKIN DISEASES; SKIN NEOPLASMS; VITILIGO;

EID: 84859773683     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.02.017     Document Type: Review

References (140)

1. Chakravarti A., Little P. Nature, nurture and human disease. Nature 2003, 421(6921):412-414.
2. Manolio T.A., Collins F.S. Genes, environment, health, and disease: facing up to complexity. Hum Hered 2007, 63(2):63-66.
3. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med 2009, 360(17):1759-1768.
4. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
5. Kruglyak L. The road to genome-wide association studies. Nat Rev Genet 2008, 9(4):314-318.
6. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720):385-389.
7. Hindorff L, Junkins H, Mehta J, Manolio T, A Catalog of Published Genome-Wide Association Studies. Available from: www.genome.gov/gwastudies.
8. Nevitt G.J., Hutchinson P.E. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996, 135(4):533-537.
9. Shao C., Zhang G., Wang G. Distribution of psoriasis in China: a nationwide screening. Proc Chin Acad Med Sci Peking Union Med Coll 1987, 2:59-65.
10. Capon F., Bijlmakers M.J., Wolf N., Quaranta M., Huffmeier U., Allen M., et al. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum Mol Genet 2008, 17(13):1938-1945.
11. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4(3):e1000041.
12. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009, 41(2):199-204.
13. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009, 41(2):205-210.
14. Huffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 2010, 42(11):996-999.
15. Ellinghaus E., Ellinghaus D., Stuart P.E., Nair R.P., Debrus S., Raelson J.V., et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010, 42(11):991-995.
16. Sun L.D., Cheng H., Wang Z.X., Zhang A.P., Wang P.G., Xu J.H., et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 2010, 42(11):1005-1009.
17. Stuart P.E., Nair R.P., Ellinghaus E., Ding J., Tejasvi T., Gudjonsson J.E., et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 2010, 42(11):1000-1004.
18. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42(11):985-990.
19. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hun Genet 2007, 80:273-290.
20. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009, 41(2):211-215.
21. Nair R.P., Stuart P.E., Nistor I., Hiremagalore R., Chia N.V., Jenisch S., et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006, 78(5):827-851.
22. Fan X., Yang S., Huang W., Wang Z.M., Sun L.D., Liang Y.H., et al. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population. PLoS Genet 2008, 4(3):e1000038.
23. Elder J.T. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 2009, 10(3):201-209.
24. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009, 361(5):496-509.
25. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004, 173(7):4273-4276.
26. Feng B.J., Sun L.D., Soltani-Arabshahi R., Bowcock A.M., Nair R.P., Stuart P., et al. Multiple Loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet 2009, 5(8):e1000606.
27. Elder J.T., Bruce A.T., Gudjonsson J.E., Johnston A., Stuart P.E., Tejasvi T., et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010, 130(5):1213-1226.
28. Bowcock A.M., Krueger J.G. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005, 5(9):699-711.
29. Krueger J.G., Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005, 64(Suppl. 2). p. ii30-6.
30. Hopkinson N.D., Doherty M., Powell R.J. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994, 53(10):675-680.
31. Wang J., Yang S., Chen J.J., Zhou S.M., He S.M., Liang Y.H., et al. Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 2007, 298(10):485-491.
32. Lau C.S., Yin G., Mok M.Y. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006, 15(11):715-719.
33. Zeng Q.Y., Chen R., Darmawan J., Xiao Z.Y., Chen S.B., Wigley R., et al. Rheumatic diseases in China. Arthritis Res Ther 2008, 10(1):R17.
34. Danchenko N., Satia J.A., Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006, 15(5):308-318.
35. Harley I.T., Kaufman K.M., Langefeld C.D., Harley J.B., Kelly J.A. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009, 10(5):285-290.
36. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(2):211-216.
37. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(9):1059-1061.
38. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40(2):204-210.
39. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358(9):900-909.
40. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1228-1233.
41. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1234-1237.
42. Yang W., Shen N., Ye D.Q., Liu Q., Zhang Y., Qian X.X., et al. Genome-wide association study in asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010, 6(2):e1000841.
43. Yang J., Yang W., Hirankarn N., Ye D.Q., Zhang Y., Pan H.F., et al. ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum Mol Genet 2011, 20(3):601-607.
44. Chung S.A., Taylor K.E., Graham R.R., Nititham J., Lee A.T., Ortmann W.A., et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 2011, 7(3):e1001323.
45. Han T.U., Bang S.Y., Kang C., Bae S.C. TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians. Arthritis Rheum 2009, 60(9):2577-2584.
46. Graham R.R., Hom G., Ortmann W., Behrens T.W. Review of recent genome-wide association scans in lupus. J Intern Med 2009, 265(6):680-688.
47. Global leprosy situation, 2007. Wkly Epidemiol Rec 2007, 82(25):225-232.
48. Shields E.D., Russell D.A., Pericak-Vance M.A. Genetic epidemiology of the susceptibility to leprosy. J Clin Invest 1987, 79(4):1139-1143.
49. Abel L., Demenais F. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island. Am J Hum Genet 1988, 42(2):256-266.
50. Abel L., Vu D.L., Oberti J., Nguyen V.T., Van V.C., Guilloud-Bataille M., et al. Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol 1995, 12(1):63-82.
51. Todd J.R., West B.C., McDonald J.C. Human leukocyte antigen and leprosy: study in northern Louisiana and review. Rev Infect Dis 1990, 12(1):63-74.
52. Siddiqui M.R., Meisner S., Tosh K., Balakrishnan K., Ghei S., Fisher S.E., et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001, 27(4):439-441.
53. Mira M.T., Alcais A., Nguyen V.T., Moraes M.O., Di Flumeri C., Vu H.T., et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004, 427(6975):636-640.
54. Alcais A., Alter A., Antoni G., Orlova M., Nguyen V.T., Singh M., et al. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 2007, 39(4):517-522.
55. Moraes M.O., Cardoso C.C., Vanderborght P.R., Pacheco A.G. Genetics of host response in leprosy. Lepr Rev 2006, 77(3):189-202.
56. Wang L.M., Kimura A., Satoh M., Mineshita S. HLA linked with leprosy in southern China: HLA-linked resistance alleles to leprosy. Int J Lepr Other Mycobact Dis 1999, 67(4):403-408.
57. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., et al. Genomewide association study of leprosy. N Engl J Med 2009, 361(27):2609-2618.
58. Zhang F., Liu H., Chen S., Low H., Sun L., Cui Y., et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet 2011, 42(12):1247-1251.
59. Le Bourhis L., Benko S., Girardin S.E. Nod1 and Nod2 in innate immunity and human inflammatory disorders. Biochem Soc Trans 2007, 35(Pt 6):1479-1484.
60. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40(8):955-962.
61. Wong S.H., Hill A.V., Vannberg F.O. Genomewide association study of leprosy. N Engl J Med 2010, 362(15):1446-1447. author reply 1447-8.
62. Schurr E., Gros P. A common genetic fingerprint in leprosy and Crohn's disease?. N Engl J Med 2009, 361(27):2666-2668.
63. Hann S.K.N.J. Vitiligo 2000, Blackwell Science, Oxford.
64. Zhang X.J., Liu J.B., Gui J.P., Li M., Xiong Q.G., Wu H.B., et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol 2004, 51(3):383-390.
65. Alkhateeb A., Fain P.R., Thody A., Bennett D.C., Spritz R.A. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003, 16(3):208-214.
66. Nath S.K., Kelly J.A., Namjou B., Lam T., Bruner G.R., Scofield R.H., et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001, 69(6):1401-1406.
67. Alkhateeb A., Stetler G.L., Old W., Talbert J., Uhlhorn C., Taylor M., et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002, 11(6):661-667.
68. Spritz R.A., Gowan K., Bennett D.C., Fain P.R. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004, 74(1):188-191.
69. Chen J.J., Huang W., Gui J.P., Yang S., Zhou F.S., Xiong Q.G., et al. A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am J Hum Genet 2005, 76(6):1057-1065.
70. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356(12):1216-1225.
71. Ren Y., Yang S., Xu S., Gao M., Huang W., Gao T., et al. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 2009, 5(6):e1000523.
72. Jin Y., Birlea S.A., Fain P.R., Spritz R.A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007, 127(11):2558-2562.
73. Zamani M., Spaepen M., Sghar S.S., Huang C., Westerhof W., Nieuweboer-Krobotova L., et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001, 145(1):90-94.
74. Arcos-Burgos M., Parodi E., Salgar M., Bedoya E., Builes J., Jaramillo D., et al. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 2002, 110(4):334-342.
75. Birlea S.A., Gowan K., Fain P.R., Spritz R.A. Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J Invest Dermatol 2010, 130(3):798-803.
76. Jin Y., Birlea S.A., Fain P.R., Gowan K., Riccardi S.L., Holland P.J., et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. New Engl J Med 2010, 362(18):1686-1697.
77. Spritz R.A. The genetics of generalized vitiligo. Curr Dir Autoimmun 2008, 10:244-257.
78. Jin Y., Birlea S.A., Fain P.R., Mailloux C.M., Riccardi S.L., Gowan K., et al. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet 2010, 42(7):576-578.
79. Quan C., Ren Y.Q., Xiang L.H., Sun L.D., Xu A.E., Gao X.H., et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 2010, 42(7):614-618.
80. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14(5):409-426.
81. Le Borgne M., Etchart N., Goubier A., Lira S.A., Sirard J.C., van Rooijen N., et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006, 24(2):191-201.
82. Kochi Y., Okada Y., Suzuki A., Ikari K., Terao C., Takahashi A., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010, 42(6):515-519.
83. Jin Y., Birlea S.A., Fain P.R., Gowan K., Riccardi S.L., Holland P.J., et al. Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol 2011, 131(6):1308-1312.
84. Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006, 118(1):152-169.
85. Morar N., Willis-Owen S.A., Moffatt M.F., Cookson W.O. The genetics of atopic dermatitis. J Allergy Clin Immunol 2006, 118(1):24-34. quiz 35-6.
86. Chien Y.H., Hwu W.L., Chiang B.L. The genetics of atopic dermatitis. Clin Rev Allergy Immunol 2007, 33(3):178-190.
87. Esparza-Gordillo J., Weidinger S., Folster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009, 41(5):596-601.
88. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38(4):441-446.
89. Sun L.D., Xiao F.L., Li Y., Zhou W.M., Tang H.Y., Tang X.F., et al. Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet 2011, 43(7):690-694.
90. Nyholt D.R., Gillespie N.A., Heath A.C., Martin N.G. Genetic basis of male pattern baldness. J Invest Dermatol 2003, 121(6):1561-1564.
91. Severi G., Sinclair R., Hopper J.L., English D.R., McCredie M.R., Boyle P., et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003, 149(6):1207-1213.
92. Ellis J.A., Stebbing M., Harrap S.B. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001, 116(3):452-455.
93. Hillmer A.M., Hanneken S., Ritzmann S., Becker T., Freudenberg J., Brockschmidt F.F., et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 2005, 77(1):140-148.
94. Hillmer A.M., Brockschmidt F.F., Hanneken S., Eigelshoven S., Steffens M., Flaquer A., et al. Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008, 40(11):1279-1281.
95. Richards J.B., Yuan X., Geller F., Waterworth D., Bataille V., Glass D., et al. Male-pattern baldness susceptibility locus at 20p11. Nat Genet 2008, 40(11):1282-1284.
96. Brockschmidt F.F., Heilmann S., Ellis J.A., Eigelshoven S., Hanneken S., Herold C., et al. Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. Br J Dermatol 2011, 165(6):1293-1302.
97. Butler P.D., Longaker M.T., Yang G.P. Current progress in keloid research and treatment. J Am Coll Surg 2008, 206(4):731-741.
98. Tuan T.L., Nichter L.S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998, 4(1):19-24.
99. Seifert O., Mrowietz U. Keloid scarring: bench and bedside. Arch Dermatol Res 2009, 301(4):259-272.
100. LeFlore I.C. Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc 1980, 72(10):947-948.
101. Marneros A.G., Norris J.E., Watanabe S., Reichenberger E., Olsen B.R. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004, 122(5):1126-1132.
102. Yan X., Gao J.H., Chen Y., Song M., Liu X.J. Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007, 23(1):32-35.
103. Shih B., Bayat A. Genetics of keloid scarring. Arch Dermatol Res 2010, 302(5):319-339.
104. Nakashima M., Chung S., Takahashi A., Kamatani N., Kawaguchi T., Tsunoda T., et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 2010, 42(9):768-771.
105. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357(21):2153-2165.
106. Marchell R.M., Judson M.A. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol 2007, 25(3):295-302.
107. Rybicki B.A., Iannuzzi M.C., Frederick M.M., Thompson B.W., Rossman M.D., Bresnitz E.A., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001, 164(11):2085-2091.
108. Chen E.S., Moller D.R. Etiology of sarcoidosis. Clin Chest Med 2008, 29(3):365-377. vii.
109. Smith G., Brownell I., Sanchez M., Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet 2008, 73(5):401-412.
110. Hofmann S., Franke A., Fischer A., Jacobs G., Nothnagel M., Gaede K.I., et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008, 40(9):1103-1106.
111. Hofmann S., Fischer A., Till A., Muller-Quernheim J., Hasler R., Franke A., et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J 2011, 38(5):1127-1135.
112. Rubin A.I., Chen E.H., Ratner D. Basal-cell carcinoma. N Engl J Med 2005, 353(21):2262-2269.
113. Lear J.T., Hoban P., Strange R.C., Fryer A.A. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes. Clin Exp Dermatol 2005, 30(1):49-55.
114. Ling G., Ahmadian A., Persson A., Unden A.B., Afink G., Williams C., et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001, 20(53):7770-7778.
115. Stacey S.N., Gudjartsson D.F., Sulem P., Bergthorsson J.T., Kumar R., Thorleifsson G., et al. common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet 2008, 40(11):1313-1318.
116. Yang S.H., Andl T., Grachtchouk V., Wang A., Liu J., Syu L.J., et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling. Nat Genet 2008, 40(9):1130-1135.
117. Stacey S.N., Sulem P., Masson G., Gudjonsson S.A., Thorleifsson G., Jakobsdottir M., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41(8):909-914.
118. Nan H., Xu M., Kraft P., Qureshi A.A., Chen C., Guo Q., et al. Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 2011, 20(18):3718-3724.
119. Han J., Qureshi A.A., Prescott J., Guo Q., Ye L., Hunter D.J., et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009, 129(2):415-421.
120. Shen J., Terry M.B., Gurvich I., Liao Y., Senie R.T., Santella R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007, 67(11):5538-5544.
121. Wu X., Amos C.I., Zhu Y., Zhao H., Grossman B.H., Shay J.W., et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003, 95(16):1211-1218.
122. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44(10):1345-1389.
123. Gruber F., Kastelan M., Brajac I., Saftic M., Peharda V., Cabrijan L., et al. Molecular and genetic mechanisms in melanoma. Coll Antropol 2008, 32(Suppl. 2):147-152.
124. Cannon-Albright L.A., Bishop D.T., Goldgar C., Skolnick M.H. Genetic predisposition to cancer. Important Adv Oncol 1991, 39-55.
125. Titus-Ernstoff L., Perry A.E., Spencer S.K., Gibson J.J., Cole B.F., Ernstoff M.S. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer 2005, 116(1):144-149.
126. Bataille V., Bishop J.A., Sasieni P., Swerdlow A.J., Pinney E., Griffiths K., et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996, 73(12):1605-1611.
127. Chang Y.M., Newton-Bishop J.A., Bishop D.T., Armstrong B.K., Bataille V., Bergman W., et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer 2009, 124(2):420-428.
128. Hollenbeak C.S., Todd M.M., Billingsley E.M., Harper G., Dyer A.M., Lengerich E.J. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005, 104(9):1962-1967.
129. Brown K.M., Macgregor S., Montgomery G.W., Craig D.W., Zhao Z.Z., Iyadurai K., et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 2008, 40(7):838-840.
130. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008, 40(7):886-891.
131. Bishop D.T., Demenais F., Iles M.M., Harland M., Taylor J.C., Corda E., et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41(8):920-925.
132. Amos C.I., Wang L.E., Lee J.E., Gershenwald J.E., Chen W.V., Fang S., et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 2011, 20(24):5012-5023.
133. Barrett J.H., Iles M.M., Harland M., Taylor J.C., Aitken J.F., Andresen P.A., et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011, 43(11):1108-1113.
134. Macgregor S., Montgomery G.W., Liu J.Z., Zhao Z.Z., Henders A.K., Stark M., et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 2011, 43(11):1114-1118.
135. Nan H., Xu M., Zhang J., Zhang M., Kraft P., Qureshi A.A., et al. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet 2011, 20(13):2673-2679.
136. Duffy D.L., Iles M.M., Glass D., Zhu G., Barrett J.H., Hoiom V., et al. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. Am J Hum Genet 2011, 87(1):6-16.
137. Hori Y., Hori H., Yamada Y., Carrera C.J., Tomonaga M., Kamihira S., et al. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia. Int J Cancer 1998, 75(1):51-56.
138. Garcia-Castellano J.M., Villanueva A., Healey J.H., Sowers R., Cordon-Cardo C., Huvos A., et al. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clin Cancer Res 2002, 8(3):782-787.
139. Falchi M., Bataille V., Hayward N.K., Duffy D.L., Bishop J.A., Pastinen T., et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009, 41(8):915-919.
140. Kingsmore S.F., Lindquist I.E., Mudge J., Gessler D.D., Beavis W.D. Genome-wide association studies: progress and potential for drug discovery and development. Nat Rev Drug Discov 2008, 7(3):221-230.